Experimental verification of a predicted novel microRNA located in human PIK3CA gene with a potential oncogenic function in colorectal cancer

被引:9
|
作者
Saleh, Ali Jason [1 ]
Soltani, Bahram M. [1 ]
Dokanehiifard, Sadat [1 ]
Medlej, Abdallah [1 ]
Tavalaei, Mahmoud [2 ]
Mowla, Seyed Javad [1 ]
机构
[1] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran
[2] Bagiatallah Univ Med Sci, Tehran, Iran
关键词
PI3K signaling; PIK3CA-miR1; Colorectal cancer; Oncogene; APPL1; TrkC; PHOSPHATIDYLINOSITOL; 3-KINASE; TARGET PREDICTION; TUMOR-SUPPRESSOR; MIRNA PROMOTERS; CELL-LINES; IDENTIFICATION; APPL1; TRANSCRIPTION; BIOGENESIS; PROTEIN;
D O I
10.1007/s13277-016-5264-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PI3K/AKT signaling is involved in cell survival, proliferation, and migration. In this pathway, PI3K alpha enzyme is composed of a regulatory protein encoded by p85 gene and a catalytic protein encoded by PIK3CA gene. Human PIK3CA locus is amplified in several cancers including lung and colorectal cancer (CRC). Therefore, microRNAs (miRNAs) that are encoded within the PIK3CA gene might have a role in cancer development. Here, we report a novel microRNA named PIK3CA-miR1 (EBI accession no. LN626315), which is located within PIK3CA gene. A DNA segment corresponding to PIK3CA-premir1 sequence was transfected in human cell lines that resulted in generation of mature exogenous PIK3CA-miR1. Following the overexpression of PIK3CA-miR1, its predicted target genes (APPL1 and TrkC) were significantly downregulated in the CRC-originated HCT116 and SW480 cell lines, detected by qRT-PCR. Then, dual luciferase assay supported the interaction of PIK3CA-miR1 with APPL1 and TrkC transcripts. Endogenous PIK3CA-miR1 expression was also detected in several cell lines (highly in HCT116 and SW480) and highly in CRC specimens. Consistently, overexpression of PIK3CA-premir1 in HCT116 and SW480 cells resulted in significant reduction of the sub-G1 cell distribution and apoptotic cell rate, as detected by flowcytometry, and resulted in increased cell proliferation, as detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. PIK3CA-miR1 overexpression also resulted in Wnt signaling upregulation detected by Top/Fop assay. Overall, accumulative evidences indicated the presence of a bona fide novel onco-miRNA encoded within the PIK3CA oncogene, which is highly expressed in colorectal cancer and has a survival effect in CRC-originated cells.
引用
收藏
页码:14089 / 14101
页数:13
相关论文
共 50 条
  • [41] Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer
    Chang, Pi-Yueh
    Chen, Jinn-Shiun
    Chang, Shih-Cheng
    Wang, Mei-Chia
    Chang, Nai-Chung
    Wen, Ying-Hao
    Tsai, Wen-Sy
    Liu, Wei-Hsiu
    Liu, Hsiu-Ling
    Lu, Jang-Jih
    ONCOTARGET, 2017, 8 (42) : 72352 - 72362
  • [42] The Spectrum, Tendency and Predictive Value of PIK3CA Mutation in Chinese Colorectal Cancer Patients
    Fu, Xinhui
    Lin, Hanjie
    Fan, Xinjuan
    Zhu, Yaxi
    Wang, Chao
    Chen, Zhiting
    Tan, Xiaoli
    Huang, Jinglin
    Cai, Yacheng
    Huang, Yan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer
    Foltran, Luisa
    De Maglio, Giovanna
    Pella, Nicoletta
    Ermacora, Paola
    Aprile, Giuseppe
    Masiero, Elena
    Giovannoni, Mariella
    Iaiza, Emiliana
    Cardellino, Giovanni Gerardo
    Lutrino, Stefania Eufemia
    Mazzer, Micol
    Giangreco, Manuela
    Pisa, Federica Edith
    Pizzolitto, Stefano
    Fasola, Gianpiero
    FUTURE ONCOLOGY, 2015, 11 (04) : 629 - 640
  • [44] The potential of PIK3CA, KRAS, BRAF, and APC hotspot mutations as a non-invasive detection method for colorectal cancer
    Alizadeh-Sedigh, Maryam
    Mahmoodzadeh, Habibollah
    Fazeli, Mohammad Sadegh
    Haddadi-Aghdam, Mohammad
    Teimoori-Toolabi, Ladan
    MOLECULAR AND CELLULAR PROBES, 2022, 63
  • [45] Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial
    Normanno, N.
    Rachiglio, A. M.
    Lambiase, M.
    Martinelli, E.
    Fenizia, F.
    Esposito, C.
    Roma, C.
    Troiani, T.
    Rizzi, D.
    Tatangelo, F.
    Botti, G.
    Maiello, E.
    Colucci, G.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2015, 26 (08) : 1710 - 1714
  • [46] PIK3CA and TP53 mutations predict overall survival of stage Ⅱ/Ⅲ colorectal cancer patients
    A-Jian Li
    Hua-Guang Li
    Er-Jiang Tang
    Wei Wu
    Ying Chen
    Hui-Hong Jiang
    Mou-Bin Lin
    Lu Yin
    World Journal of Gastroenterology, 2018, (05) : 631 - 640
  • [47] Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis
    Mei, Z. B.
    Duan, C. Y.
    Li, C. B.
    Cui, L.
    Ogino, S.
    ANNALS OF ONCOLOGY, 2016, 27 (10) : 1836 - 1848
  • [48] Survey of KRAS, BRAF and PIK3CA mutational status in 209 consecutive Italian colorectal cancer patients
    Bozzao, Cristina
    Varvara, Dora
    Piglionica, Marilidia
    Bagnulo, Rosanna
    Forte, Giovanna
    Patruno, Margherita
    Russo, Silvana
    Piscitelli, Domenico
    Stella, Alessandro
    Resta, Nicoletta
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2012, 27 (04) : E366 - E374
  • [49] Association between the lengths of GT dinucleotide repeat in the PIK3CA gene with breast cancer risk
    Heshmatpour, Najmeh
    Hematti, Simin
    Hejazi, Seyyed Hossein
    Safari, Forousan
    Tavassoli, Manoochehr
    MEDICAL ONCOLOGY, 2014, 31 (07)
  • [50] Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells
    Zumwalt, Timothy J.
    Wodarz, Dominik
    Komarova, Natalia L.
    Toden, Shusuke
    Turner, Jacob
    Cardenas, Jacob
    Burn, John
    Chan, Andrew T.
    Boland, C. Richard
    Goel, Ajay
    CANCER PREVENTION RESEARCH, 2017, 10 (03) : 208 - 218